PatientIQ
PatientIQ Raises $30M Series C for Patient Outcomes Intelligence
PatientIQ announced $30M in Series C financing on September 3, 2026. PatientIQ raised a $30 million Series C led by Hughes and Company to deepen its presence across existing specialties and health systems, expand its real-world evidence platform for medical device and life sciences companies, and build a direct-to-patient commerce experience.
Round details
The financing includes backing from Hughes and Company. The company did not publish a valuation with the announcement.
- Round: Series C
- Capital announced: $30M
How the company plans to use the capital
PatientIQ said the financing will support deepening its presence across existing specialties and health systems, expanding its real-world evidence platform for medical device and life sciences companies, and building a direct-to-patient commerce experience.
Why this matters for GTM teams
PatientIQ said it is trusted by more than 870 healthcare organizations and plans to expand its real-world evidence platform for medical device and life sciences companies.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: PatientIQ Series C announcement.
Company Info
Investors (1)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started